[Character of carcinogenic activity of orthotolidine under the effects of radiation].
D000232:Adenofibroma / Q000453:epidemiology; D000236:Adenoma / Q000453:epidemiology; D000818:Animals; D001859:Bone Neoplasms / Q000453:epidemiology; D002273:Carcinogens; D002277:Carcinoma / Q000453:epidemiology; D005260:Female; D005350:Fibroma / Q000453:epidemiology; D007889:Leiomyoma / Q000453:epidemiology; D007945:Leukemia, Lymphoid / Q000453:epidemiology; D007951:Leukemia, Myeloid / Q000453:epidemiology; D008113:Liver Neoplasms / Q000453:epidemiology; D008228:Lymphoma, Non-Hodgkin / Q000453:epidemiology; D008325:Mammary Neoplasms, Experimental / Q000453:epidemiology; D009362:Neoplasm Metastasis; D009374:Neoplasms, Experimental / Q000453:epidemiology* / Q000401:mortality; D009378:Neoplasms, Multiple Primary / Q000453:epidemiology; D012516:Osteosarcoma / Q000453:epidemiology; D011830:Radiation Effects; D051381:Rats; D012208:Rhabdomyosarcoma / Q000453:epidemiology; D012509:Sarcoma / Q000453:epidemiology; D012626:Sebaceous Gland Neoplasms / Q000453:epidemiology; D012878:Skin Neoplasms / Q000453:epidemiology; D013997:Time Factors; D014594:Uterine Neoplasms / Q000453:epidemiology
D002273:Carcinogens
Kharakter blastomogennoĭ aktivnosti ortotolidina pri luchevom vozdeĭstvii.